Graphic header for the Information Technology Laboratory home page. This includes the statment: ITL is supporting the information technology industry with measurements, standards, and research.
Healthcare graphic
copyright Photodisc

Conference Sponsors:

The Biotechnology Council (ASME, BMES, HIMSS, IEEE and SBE part of AIChE) and
the National Institute of Standards and Technology (NIST)

 

 

Economic Strategy for
Healthcare through Bio and Information Standards and Technologies
September 25, 2007

Agenda
 

Monday, September 24, 2007
 

"Systems Biology and Systems Medicine: Predictive, Personalized, Preventive and Participatory (P4)", Lee Hood, Institute for Systems Biology, Seattle

Tuesday, September 25, 2007
 

NIST Intro, Michael D. Amos, Ph.D., Biosciences Advisor, NIST

 

Introduction of Jerry Grossman – Honorary Chairman
Senior Fellow and Director, Harvard/Kennedy School
Health Care Delivery Project and Chairman Emeritus of New England Medical Center (past member of the Boston Federal Reserve Board)
 

Welcome:  Dr. James Turner,
NIST Deputy Director
 

Introduction and Welcome: Connie Morella,
U.S. Ambassador to OECD
 

Secretary Michael Leavitt-HHS
  Keynote Address:
"Consumers: Shifting the Health Paradigm" Peter Neupert, Corporate Vice President for Health Strategy, Microsoft Corporation
  Featured Presentations:
  "The Role of Biotechnology and Bioinformatics in FDA's Critical Path Initiative" Janet Woodcock, Deputy Commission, FDA
 

"Biotech 2007: A Global Transformation"; G. Steven Burrill, CEO, Burrill & Company
  "Approaches to Developing Government R&D Programs";
Greg Tassey, Senior Economist, NIST
 

"The Potential of Biotechnology and Bioinformatics for Public Health" Anthony Arunel, SGEAU, OECD,

  "Technology Innovation Program", Marc Stanley, Acting Director Technology Innovation Program NIST
 

ASSESSING HEALTH CARE BIO AND INFORMATION TECHNOLOGY ECONOMICS
 

Roundtable:  Marketplace Economics

Moderator:
Vijay Vaitheeswaran,
Correspondent  to The Economist

 

Participants:

Patrick Yang,
Executive VP, Genentech

Allan Korn, M.D.,
Senior VP and Chief Medical Officer, BC/BS

Mitchell Higashi, PhD.,
Senior Director, Health Economics & Outcomes Research,
GE Healthcare

G. Steven Burrill, CEO, Burrill & Company

Greg Tassey, Senior Economist, NIST

 
 

Assessing Emerging Technology Benefits and Barriers

Panelists                                               

David Whitlinger,
President and Board Chairman, Continua
Panel Co-organizer and Facilitor

Mostafa Analoui, PhD.,
Senior Director, Pfizer Global Research and Development

Michael Hehenberger,
Solutions Executive, IBM Global Innovation, Health Care and Life Sciences
                                               
Rainu Kaushal,
Department of Medicine, Brigham and Women’s Hospital; appointment at Weill-Cornell School of Medicine

 Deepak Ayyagari, PhD
Secretary, Continua Health Alliance,
Principal Scientist, Personal Healthcare Technologies, Sharp

 
NIST is an agency of the
U.S. Department of Commerce
Privacy statement / security notice / accessibility statement / Disclaimer / FOIA
Date created: September 26, 2007  |  Last updated: October 10, 2007

For additional information, e-mail ITL